Development and validation of a risk score predicting risk of colorectal cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 11, 2014, Pages 2543-2552

  Steffen, Annika ^a   MacInnis, Robert J ^b,c   Joshy, Grace ^d   Giles, Graham G ^b,c   Banks, Emily ^d,e   Roder, David ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d The Australian National University   (Australia)

^e SAX INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; VALIDATION STUDY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; MIDDLE AGED;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VALIDATION STUDIES AS TOPIC;

EID: 84920134143     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0206     Document Type: Article

References (54)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM.GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer-Base No. 10. 2010 [cited 2011 09/12]; Available from: http://globocan.iarc.fr
2. Bustin SA, Murphy J. RNA biomarkers in colorectal cancer. Methods 2013;59:116-25.
3. Australian Institute of Health and Welfare. National Bowel Cancer Screening Program monitoring report: phase 2, July 2008-June 2011. Cancer Series no. 66. Cat. No. CAN 62. Canberra: AIHW; 2012.
4. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95.
5. von Karsa L, Anttila A, Ronco G, et al. Cancer Screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. Lyon: International Agency for Research on Cancer. [cited 2012 Oct. 30]. Available from: http://ec.europa.eu/health/ph-determinants/genetics/documents/cancer-screening.pdf; 2008.
6. Bretthauer M, Kalager M. Principles, effectiveness and caveats in screening for cancer. Br J Surg 2013;100:55-65.
7. Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011;105 Suppl 2:S77-81.
8. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA 2008;300:2765-78.
9. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, Physical Actitivity, and the Prevention of Cancer: A Global Perspective. Washington DC: AICR; 2007.
10. World Cancer Research Fund, American Institute for Cancer Research. Continuous Update Project. Available from: http://www.dietandcancerreport.org/cup/current-progress/colorectal-cancer.php (last access: 04/10/2012); 2011.
11. Moons KG, Altman DG, Vergouwe Y, Royston P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 2009;338:b606.
12. Stegeman I, Bossuyt PM. Cancer risk models and preselection for screening. Cancer Epidemiol 2012;36:461-9.
13. Win AK, Macinnis RJ, Hopper JL, Jenkins MA. Risk prediction models for colorectal cancer: a review. Cancer Epidemiol Biomarkers Prev 2012;21:398-410.
14. Freedman AN, Slattery ML, Ballard-Barbash R, Willis G, Cann BJ, Pee D, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol 2009;27:686-93.
15. Colditz GA, Atwood KA, Emmons K, Monson RR, Willett WC, Trichopoulos D, et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control 2000;11:477-88.
16. Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am J Med 2007;120:257-63.
17. Ma E, Sasazuki S, Iwasaki M, Sawada N, Inoue M. 10-Year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men. Cancer Epidemiol 2011;34:534-41.
18. Wei EK, Colditz GA, Giovannucci EL, Fuchs CS, Rosner BA. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study.AmJ Epidemiol 2009;170:863-72.
19. 45 and Up Study Collaborators Banks E, Redman S, Jorm L, Armstrong B, Bauman A, et al. Cohort profile: the 45 and up study. Int J Epidemiol 2008;37:941-7.
20. Sax Institute. 45 and Up Study Technical Note 1: Missing or Invalid Values; 2013. [cited 2014 June 22]. Available from: https://www.saxinstitute.org.au/wp-content/uploads/Technical-Note-missing-or-invalid-values.pdf.
21. Sax Institute. The Baseline Questionnaires. [cited 2014 June 22]. Available from: https://www.saxinstitute.org.au/our-work/45-up-study/questionnaires/.
22. Kemp A, Preen DB, Saunders C, Holman CD, Bulsara M, Rogers K, et al. Ascertaining invasive breast cancer cases; the validity of administrative and self-reported data sources in Australia. BMC Med Res Methodol 2013;13:17.
23. Centre for Health Record Linkage. [cited 2012 Nov. 17]. Available from: http://www.cherel.org.au/.
24. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ 2002;156:69-70.
25. Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C. Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol 2012;23:1403-15.
26. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 2006;59:1087-91.
27. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b2393.
28. van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999;18:681-94.
29. Allison PD. Imputation of categorical variables with PROC MI. Proceedings 2005, 113-30, pp. 1-14.
30. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007;16:219-42.
31. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999;8:3-15.
32. Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci 2007;8:206-13.
33. Wood AM, White IR, Royston P. How should variable selection be performed with multiply imputed data? Stat Med 2008;27:3227-46.
34. Vergouwe Y, Royston P, Moons KG, Altman DG. Development and validation of a prediction model with missing predictor data: a practical approach. J Clin Epidemiol 2010;63:205-14.
35. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.
36. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004;23:2109-23.
37. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72.
38. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21.
39. Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol 2012;176:473-81.
40. Bewick V, Cheek L, Ball J. Statistics review 13: receiver operating characteristic curves. Crit Care 2004;8:508-12.
41. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-5.
42. Johnston D, Gong G. rmap: Risk Model Assessment Package. R package version 0.01-02; 2011.
43. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, ISBN 3-900051-07-0; 2011. Available from: http://www.R-project.org/
44. Deng L, Gui Z, Zhao L, Wang J, Shen L. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci 2012;57:1576-85.
45. Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2012;9:e1001352.
46. Kavanagh AM, Giovannucci EL, Fuchs CS, Colditz GA. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control 1998;9:455-62.
47. Steffen A, Weber M, Roder D, Banks E. Colorectal cancer screening and subsequent incidence of colorectal cancer: results from the 45 and Up Study. Medical Journal of Australia (accepted for publication).
48. Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 2008;54:17-23.
49. Park Y, Freedman AN, Gail MH, Pee D, Hollenbeck A, Schatzkin A, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol 2009;27:694-8.
50. Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart 2012;98:691-8.
51. Tice JA, Cummings SR, Ziv E, Kerlikowske K. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 2005;94:115-22.
52. MacKarem G, Roche CA, Hughes KS. The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age. Breast J 2001;7:34-9.
53. Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006;98:1215-26.
54. Gail MH. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst 2008;100:1037-41.